LIGANDAL
Ligandal is pioneering Predictive Interactomics™, coupling zero-shot predictive AI with generative peptides to deliver to virtually any cell, tissue or organ.
Ligandal solves the delivery problem and enables precision genetic medicine. We package cell- and tissue-specific delivery technologies for gene therapies and gene editors such as CRISPR and mRNA, and can delivery broad classes of molecular matter.
By combining machine learning models, peptide chemistry, nanotechnology, and biological studies with our next-generation AI engine, we allow for the rapid discovery, design and development of novel peptide therapeutics and delivery systems geared for the 21st century of medicine.
We are backed by 13 years of foundational R&D and over 70 pending global patents.
li·gand
noun
BIOCHEMISTRY
a molecule that binds to another (usually larger) molecule.
Imagine a world where we can reprogram biology precisely and predictively for the betterment of humankind and the planet. We believe in that world and want to see the ultimate good for global health and longevity arise from these capabilities and technologies, their implementation, and their distribution.
Ligandal is a leader in the interface of computational biology, machine learning, and AI with nanomaterials and delivery technologies for developing the next generation of precision medicine. Our platform of peptide-based nanomaterials enables applications for gene therapy, gene editing, regenerative medicine, immunotherapy, and next-generation antidote-vaccine technologies to benefit our civilization.
Ligandal solves the delivery problem and enables precision genetic medicine. We package cell- and tissue-specific delivery technologies for gene therapies and gene editors such as CRISPR and mRNA, and can delivery broad classes of molecular matter.
By combining machine learning models, peptide chemistry, nanotechnology, and biological studies with our next-generation AI engine, we allow for the rapid discovery, design and development of novel peptide therapeutics and delivery systems geared for the 21st century of medicine.
We are backed by 13 years of foundational R&D and over 70 pending global patents.
li·gand
noun
BIOCHEMISTRY
a molecule that binds to another (usually larger) molecule.
Imagine a world where we can reprogram biology precisely and predictively for the betterment of humankind and the planet. We believe in that world and want to see the ultimate good for global health and longevity arise from these capabilities and technologies, their implementation, and their distribution.
Ligandal is a leader in the interface of computational biology, machine learning, and AI with nanomaterials and delivery technologies for developing the next generation of precision medicine. Our platform of peptide-based nanomaterials enables applications for gene therapy, gene editing, regenerative medicine, immunotherapy, and next-generation antidote-vaccine technologies to benefit our civilization.